Neutropenia: occurrence and management in women with breast cancer receiving chemotherapy

Neutropenia: occurrence and management in women with breast cancer receiving chemotherapy

OBJECTIVES: to identify the prevalence, and describe the management of, neutropenia throughout the chemotherapy treatment among women with breast cancer.METHODS: observational study, cycles of chemotherapy. 116 neutropenic events were recorded, and 63.3% of the patients presented neutropenia at some point of their treatment, 46.5% of these presenting grade II. The management used was temporary suspension between the cycles and the mean number of delays was 6 days. The study was prospective and longitudinal, where the evaluation of the hematological toxicities was undertaken at each cycle of chemotherapy, whether neoadjuvant or adjuvant.RESULTS: 79 women were included, who received 572 cycles. However, the reasons for the suspensions were the lack of a space in the chemotherapy center, followed by neutropenia.CONCLUSION: neutropenia is one of the most common and serious adverse events observed during the chemotherapy. Nursing must invest in research regarding this adverse event and in management strategies for organizing the public health system, so as to offer quality care.

Saved in:
Bibliographic Details
Main Authors: Nascimento,Talita Garcia do, Andrade,Marceila de, Oliveira,Rosemeire Aparecida de, Almeida,Ana Maria de, Gozzo,Thais de Oliveira
Format: Digital revista
Language:English
Published: Escola de Enfermagem de Ribeirão Preto / Universidade de São Paulo 2014
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-11692014000200301
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0104-11692014000200301
record_format ojs
spelling oai:scielo:S0104-116920140002003012015-09-29Neutropenia: occurrence and management in women with breast cancer receiving chemotherapyNascimento,Talita Garcia doAndrade,Marceila deOliveira,Rosemeire Aparecida deAlmeida,Ana Maria deGozzo,Thais de Oliveira Nursing Breast Neoplasms Drug Therapy/adverse effects OBJECTIVES: to identify the prevalence, and describe the management of, neutropenia throughout the chemotherapy treatment among women with breast cancer.METHODS: observational study, cycles of chemotherapy. 116 neutropenic events were recorded, and 63.3% of the patients presented neutropenia at some point of their treatment, 46.5% of these presenting grade II. The management used was temporary suspension between the cycles and the mean number of delays was 6 days. The study was prospective and longitudinal, where the evaluation of the hematological toxicities was undertaken at each cycle of chemotherapy, whether neoadjuvant or adjuvant.RESULTS: 79 women were included, who received 572 cycles. However, the reasons for the suspensions were the lack of a space in the chemotherapy center, followed by neutropenia.CONCLUSION: neutropenia is one of the most common and serious adverse events observed during the chemotherapy. Nursing must invest in research regarding this adverse event and in management strategies for organizing the public health system, so as to offer quality care.info:eu-repo/semantics/openAccessEscola de Enfermagem de Ribeirão Preto / Universidade de São PauloRevista Latino-Americana de Enfermagem v.22 n.2 20142014-04-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-11692014000200301en10.1590/0104-1169.3305.2416
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Nascimento,Talita Garcia do
Andrade,Marceila de
Oliveira,Rosemeire Aparecida de
Almeida,Ana Maria de
Gozzo,Thais de Oliveira
spellingShingle Nascimento,Talita Garcia do
Andrade,Marceila de
Oliveira,Rosemeire Aparecida de
Almeida,Ana Maria de
Gozzo,Thais de Oliveira
Neutropenia: occurrence and management in women with breast cancer receiving chemotherapy
author_facet Nascimento,Talita Garcia do
Andrade,Marceila de
Oliveira,Rosemeire Aparecida de
Almeida,Ana Maria de
Gozzo,Thais de Oliveira
author_sort Nascimento,Talita Garcia do
title Neutropenia: occurrence and management in women with breast cancer receiving chemotherapy
title_short Neutropenia: occurrence and management in women with breast cancer receiving chemotherapy
title_full Neutropenia: occurrence and management in women with breast cancer receiving chemotherapy
title_fullStr Neutropenia: occurrence and management in women with breast cancer receiving chemotherapy
title_full_unstemmed Neutropenia: occurrence and management in women with breast cancer receiving chemotherapy
title_sort neutropenia: occurrence and management in women with breast cancer receiving chemotherapy
description OBJECTIVES: to identify the prevalence, and describe the management of, neutropenia throughout the chemotherapy treatment among women with breast cancer.METHODS: observational study, cycles of chemotherapy. 116 neutropenic events were recorded, and 63.3% of the patients presented neutropenia at some point of their treatment, 46.5% of these presenting grade II. The management used was temporary suspension between the cycles and the mean number of delays was 6 days. The study was prospective and longitudinal, where the evaluation of the hematological toxicities was undertaken at each cycle of chemotherapy, whether neoadjuvant or adjuvant.RESULTS: 79 women were included, who received 572 cycles. However, the reasons for the suspensions were the lack of a space in the chemotherapy center, followed by neutropenia.CONCLUSION: neutropenia is one of the most common and serious adverse events observed during the chemotherapy. Nursing must invest in research regarding this adverse event and in management strategies for organizing the public health system, so as to offer quality care.
publisher Escola de Enfermagem de Ribeirão Preto / Universidade de São Paulo
publishDate 2014
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-11692014000200301
work_keys_str_mv AT nascimentotalitagarciado neutropeniaoccurrenceandmanagementinwomenwithbreastcancerreceivingchemotherapy
AT andrademarceilade neutropeniaoccurrenceandmanagementinwomenwithbreastcancerreceivingchemotherapy
AT oliveirarosemeireaparecidade neutropeniaoccurrenceandmanagementinwomenwithbreastcancerreceivingchemotherapy
AT almeidaanamariade neutropeniaoccurrenceandmanagementinwomenwithbreastcancerreceivingchemotherapy
AT gozzothaisdeoliveira neutropeniaoccurrenceandmanagementinwomenwithbreastcancerreceivingchemotherapy
_version_ 1756408454641090560

Similar Items